We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

عن Pfizer NOVUSCIENTIA

Novuscientia هو التطبيق المحمول المصممة خصيصا للأطباء اليوم.

Novuscientia is a mobile app designed especially for today’s clinicians. It is has been developed to be compatible with both iOS and Android and downloadable to both phone and tablets. It was created with the current practice of Filipino doctors in mind. Novuscientia is source of important and relevant information to help you get updated in your clinical practice, at your convenience. Online features of this medical app include cme videos on disease, on treatment approach as well as information on select Pfizer products. Slide presentations on the select topics can also be viewed online. It also links doctors to Pfizer’s Medical Information (MI) homepage to facilitate search for information through email request for articles that go straight to our MI hub. Drug information is also available to aid accurate prescriptions of preferred therapeutic regimen. Patient management tools such as risk calculators are also accessible. Offline features include scientific evidence behind current Pfizer portfolio and a bi-monthly release of articles and features. With regular notifications, you will be advised on new information that can be viewed in the app.

تحديث لأحدث إصدار 2.1.8

Last updated on 02/02/2020

Android 10 support added

جاري في الترجمة...

معلومات أكثر ل تطبيق

احدث اصدار

طلب Pfizer NOVUSCIENTIA تحديث 2.1.8

محمل

Ali Çevik

Android متطلبات النظام

Android 5.0+

عرض المزيد

Pfizer NOVUSCIENTIA لقطات الشاشة

اللغات
اشترك في APKPure
كن أول من يحصل على الإصدارات السابقة والأخبار والأدلة لأفضل ألعاب وتطبيقات الأندرويد.
ًلا، شكرا
اشتراك
تم الاشتراك بنجاح!
أنت مشترك الآن في APKPure.
اشترك في APKPure
كن أول من يحصل على الإصدارات السابقة والأخبار والأدلة لأفضل ألعاب وتطبيقات الأندرويد.
ًلا، شكرا
اشتراك
نجاح!
لقد اشتركت في أخبار لدينا الآن لدينا.